share_log

Further Weakness as Jinneng Science&TechnologyLtd (SHSE:603113) Drops 7.7% This Week, Taking Three-year Losses to 61%

Further Weakness as Jinneng Science&TechnologyLtd (SHSE:603113) Drops 7.7% This Week, Taking Three-year Losses to 61%

金能科技股份有限公司(SHSE: 603113)本週下跌7.7%,三年跌幅至61%,進一步疲軟
Simply Wall St ·  03/28 02:40

The truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term Jinneng Science&Technology Co.,Ltd (SHSE:603113) shareholders have had a particularly rough ride in the last three year. Unfortunately, they have held through a 64% decline in the share price in that time. And the ride hasn't got any smoother in recent times over the last year, with the price 32% lower in that time. The falls have accelerated recently, with the share price down 18% in the last three months.

事實是,如果你投資足夠長的時間,你最終會有一些虧損的股票。但從長遠來看,金能科技股份有限公司, Ltd(上海證券交易所股票代碼:603113)的股東在過去三年中經歷了特別艱難的經歷。不幸的是,他們在這段時間內股價下跌了64%。而且在過去的一年裏,這種行程並沒有變得更加順利,同期價格下降了32%。最近跌勢加速,股價在過去三個月中下跌了18%。

If the past week is anything to go by, investor sentiment for Jinneng Science&TechnologyLtd isn't positive, so let's see if there's a mismatch between fundamentals and the share price.

如果說過去一週有意義的話,投資者對金能科技有限公司的情緒並不樂觀,所以讓我們看看基本面和股價之間是否存在不匹配的情況。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

在他的文章中 格雷厄姆和多茲維爾的超級投資者 禾倫·巴菲特描述了股價如何並不總是合理地反映企業的價值。通過比較每股收益(EPS)和一段時間內的股價變化,我們可以了解投資者對公司的態度是如何隨着時間的推移而變化的。

Jinneng Science&TechnologyLtd saw its share price decline over the three years in which its EPS also dropped, falling to a loss. Since the company has fallen to a loss making position, it's hard to compare the change in EPS with the share price change. However, we can say we'd expect to see a falling share price in this scenario.

金能科技有限公司的股價在三年中下跌,其每股收益也下降至虧損。由於該公司已跌至虧損狀態,因此很難將每股收益的變化與股價的變化進行比較。但是,我們可以說,在這種情況下,我們預計股價將下跌。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨着時間的推移)如下圖所示(點擊查看確切數字)。

earnings-per-share-growth
SHSE:603113 Earnings Per Share Growth March 28th 2024
SHSE: 603113 每股收益增長 2024 年 3 月 28 日

This free interactive report on Jinneng Science&TechnologyLtd's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

如果你想進一步調查金能科技有限公司的收益、收入和現金流,這份關於金能科技有限公司收益、收入和現金流的免費互動報告是一個很好的起點。

What About Dividends?

分紅呢?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Jinneng Science&TechnologyLtd, it has a TSR of -61% for the last 3 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.

重要的是要考慮任何給定股票的股東總回報率和股價回報率。股東總回報率是一種回報計算方法,它考慮了現金分紅的價值(假設收到的任何股息都經過再投資)以及任何貼現資本籌集和分拆的計算價值。因此,對於支付豐厚股息的公司來說,股東總回報率通常遠高於股價回報率。就金能科技有限公司而言,其過去三年的股東回報率爲-61%。這超過了我們之前提到的其股價回報率。因此,該公司支付的股息提高了 股東回報。

A Different Perspective

不同的視角

While the broader market lost about 15% in the twelve months, Jinneng Science&TechnologyLtd shareholders did even worse, losing 31% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 9% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. It's always interesting to track share price performance over the longer term. But to understand Jinneng Science&TechnologyLtd better, we need to consider many other factors. For instance, we've identified 1 warning sign for Jinneng Science&TechnologyLtd that you should be aware of.

儘管整個市場在十二個月中下跌了約15%,但金能科技有限公司股東的表現甚至更糟,損失了31%(甚至包括股息)。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。不幸的是,去年的表現可能預示着尚未解決的挑戰,因爲它比過去五年中9%的年化虧損還要糟糕。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。長期追蹤股價表現總是很有意思的。但是,要更好地了解金能科技股份有限公司,我們需要考慮許多其他因素。例如,我們已經確定了金能科技有限公司的1個警告標誌,你應該注意這個標誌。

Of course Jinneng Science&TechnologyLtd may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

當然,金能科技股份有限公司可能不是最好的買入股票。因此,您可能希望看到這批免費的成長股。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論